CLOs on the Move

CHF Solutions Inc

www.chf-solutions.com

 
CHF Solutions is an early stage company focused on commercializing the Aquadex FlexFlow system. Our objective is to improve the quality of life for patients with heart failure and related conditions, such as fluid overload. At CHF Solutions, we are committed to the relentless pursuit of identifying and developing innovative solutions to address unmet clinical needs with the goal of benefiting patients, medical practitioners, and the broader healthcare community.
  • Number of Employees: 25-100
  • Annual Revenue: $0-1 Million

Executives

Name Title Contact Details

Similar Companies

Source One Medical

Source One Medical has helped transform thousands of lives for more than 10 years. Any product from Source One can help increase your mobility and get you back to all those activities you miss so much. If you can increase the quality of your life with a

Joshi Medical Svc

Joshi Medical Svc is a North Billerica, MA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Miach Orthopaedics

Miach Orthopaedics, Inc. is a privately held company located in Westborough, Massachusetts, dedicated to developing bio-engineered surgical implants for connective tissue restoration. The company`s initial focus is the Bridge-Enhanced® ACL Restoration (BEAR®) Implant, which represents a paradigm shift in the treatment of ACL tears from reconstruction to restoration. The BEAR technology was pioneered by Martha Murray, M.D., founder of Miach Orthopaedics, at the Boston Children`s Hospital Department of Orthopedic Surgery, with initial research funding provided by the NFL Players Association, Boston Children`s Hospital and the National Institutes of Health.

ArthroSurface

ArthroSurface is one of the leading providers in Healthcare, Pharmaceuticals, and Biotech. It is based in Franklin, MA. To find more information about ArthroSurface, please visit www.arthrosurface.com

Seno Medical Instruments

Seno Medical Instruments, Inc. is a San Antonio, Texas-based medical imaging company committed to the development and commercialization of a new modality in cancer diagnosis: opto-acoustic imaging. Seno`s Imagio breast imaging system fuses opto-acoustic technology with ultrasound to generate functional and anatomical images of the breast. The opto-acoustic images provide a unique blood map in and around suspicious breast masses while the ultrasound provides a traditional anatomic image. Through the appearance or absence of the two hallmark indicators of cancer – angiogenesis and deoxygenation – Seno believes that the Imagio OA breast imaging system will be a more effective tool to help radiologists confirm or rule out malignancy than current diagnostic imaging modalities – without exposing patients to potentially harmful ionizing radiation (x-rays) or contrast agents.